Top ministers are understood to be working on a scheme to bring children from Gaza to the UK for NHS medical care, with plans ...

She’d been fit and healthy all her life. Then with her first pregnancy she got gestational diabetes. Over the coming years things just cascaded, puzzling doctors until she finally got a scary ...

Received U.S. FDA approval for EMPAVELI® (pegcetacoplan) for treatment of patients 12 years and older with C3G and primary IC-MPGNAnnounced capped royalty purchase agreement with Sobi under which Apel ...

Received U.S. FDA approval for EMPAVELI® (pegcetacoplan) for treatment of patients 12 years and older with C3G and primary IC-MPGN ...

Trial evaluated number of supplemental injections needed for the treatment of DME for patients on ILUVIEN versus the ...

Treatments for uveitic macular edema, including systemic and local options, were among the topics debated at the Congress on Controversies in Ophthalmology.

Patients with idiopathic intracranial hypertension who use a GLP-1 receptor agonist are less likely to experience symptoms, require medications, or undergo surgery.

Fintel reports that on July 18, 2025, Jefferies initiated coverage of Stoke Therapeutics (NasdaqGS:STOK) with a Buy recommendation. Analyst Price Forecast Suggests 84.80% Upside As of July 17, 2025, ...

Autosomal dominant optic atrophy (ADOA) causes progressive childhood blindness — but what if we could stop it? Boston Children's Hospital researchers Drs. Thomas Schwarz and Chen Ding have identified ...

Autosomal dominant optic atrophy (ADOA), the most common genetic optic neuropathy, is an insidious disease. It often presents slowly during childhood by way of blurry vision, trouble reading or ...

A mom's persistence leads to a rare eye condition diagnosis after doctors dismissed early signs, raising awareness on ...